Sitemap Contact

News

    See MoreSymphogen-Biovitrum Phase II Clinical Trial Initiated
    See MoreSymphogen Enters into strategic collaboration with Genentech for antibody thera-peutics
    See MoreBiovitrum and Symphogen Initiates a Second Clinical study with a Novel Treatment of Hemolytic Diseases
  • See MoreMore news

Events

    See MoreSLS Venture's CEO & Chairman Conference 2008
  • September 15 2008 Copenhagen, Denmark
    See MorePharmaceutical Strategic Alliances 2008
  • September 23 - 25, 2008 New York, USA
    See MoreBioEurope 2008
  • November 17 - 19, 2008 Hamburg, Germany
    See MoreJP Morgan 27th Annual Healthcare Conference
  • January 12 - 15, 2009 San Francisco
  • More events

Shortcuts

    Partners
  • See MoreBiovitrum
  • See MoreMeiji Seika Kaisha
  • See MoreGenentech
    International Documents
  • See MoreBioWorld Today
  • See MoreThe Japan Times
    Vacant Jobs
  • See MoreFACS scientist
  • SYMPHOGEN A/S
  • Elektrovej Building 375
  • 2800 Lyngby, Denmark
  • Tel. +45 4526 5050
  • Fax. +45 4526 5060
  • info@symphogen.com
  • www.symphogen.com